Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade

BACKGROUND: Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yung, Mingo Ming Ho, Chan, David Wai, Liu, Vincent Wing Sun, Yao, Kwok-Ming, Ngan, Hextan Yuen-Sheung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702529/
https://www.ncbi.nlm.nih.gov/pubmed/23819460
http://dx.doi.org/10.1186/1471-2407-13-327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702529/
https://www.ncbi.nlm.nih.gov/pubmed/23819460
http://dx.doi.org/10.1186/1471-2407-13-327

Ejemplares similares